Search

everythinglearnresearchcommunity

for

Search:↓

New drug shows promise for better hair growth in baldness treatment.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Yonnyuniksoogobon-dan taken orally promotes hair growth by affecting growth factors in hair roots.

Steroid hormones can help treat aging issues and improve health in elderly people.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

New compounds may help treat prostate cancer by reducing cell growth.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Aging causes hair to gray and thin, with the timing of graying varying by race, and factors like oxidative stress and genetics can lead to hair loss.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

New nanofiber technology improves wound healing by supporting cell growth and delivering treatments directly to the wound.

PGD2 stops hair growth and is higher in bald men with AGA.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.